InsidersTradesSigma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B: insider trades · Hong Kong · HKEX
HKEX:immuneonco-biopharmaceuticals-shanghai-inc-b-h-sharesHK·HKEXMcap 1.5Bn€Healthcare
Discover the full management transaction log of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B, a publicly traded company based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Operating in the Healthcare sector, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B has recorded 1 public disclosures. Market capitalisation: €1.5bn. The latest transaction was disclosed on 14 May 2026 — Purchase. Among the most active insiders: Tian Wenzhi. The full history is accessible without an account.
1
Insider Decl.
0
Thresholds
€21,094
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
3.51 €
Analyst consensus
Income statement
Revenue154.3 M€
Gross profit153.2 M€99% margin
Net income−218.6 M€-141.7% margin
Valuation
P/Book1.7x
Beta0.41
Balance sheet & cash
Market cap1.51 Bn€
Total debt228.0 M€
Free Cash Flow−203.9 M€
Debt / Equity29%
Profitability & ownership
ROE-29.9%
ROA-13.8%
% insiders38.4%
% institutions2.5%
Last declaration on 14 May 2026
Declarations0 total
No declarations found
0 of 0 declarations